phymatology
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients, aged 18 years, were selected to receive tumor cell reduction combined with intraperitoneal thermoperfusion chemotherapy without gender limitation
Exclusion criteria
Exclusion criteria: ? body mass index (BMI) > 30 kg/m2; ? is suffering from acute or chronic respiratory disease; ? Patients with moderate or large amount of pleural effusion before surgery; ? History of taking ß2 receptor agonists, ipratropium bromide aerosol, glucocorticoids or theophylline and its derivatives within the past 14 days; (5) Patients with implantable cardiac defibrillators, pacemakers and other implants with electrical activity; ? serious cardiopulmonary dysfunction; ? Severe hemodynamic instability, severe cachexia malnutrition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pulmonary complications were followed up;average length of stay; | — |
Secondary
| Measure | Time frame |
|---|---|
| TNF-a;IL-6;iPEEP;Respiratory parameters (Ppeak, Pplat, Pmean, Cdyn, PO2, oxygenation index, fractional flow rate, dead cavity rate);Association of iPEEP levels with postoperative pulmonary complications; | — |
Countries
China
Contacts
Beijing Shijitan Hospital, Capital Medical University